Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type & End-User In 2020, the valuation of the Global Hemostats and Tissue Sealants Market size was USD 6.35 billion. As per the SMR analysis, the market is set to reach USD 11.27 billion by 2028, projecting a CAGR of 8.93 % throughout the forecasted period of 2020-2028. Hemostats and Sealants are the medical devices implemented to prevent hemorrhage and bleeding caused due to injuries and surgical processes, resulting in progressive healing. The Coagulation system comprises proteins and blood cells responsible for blood clots leading to hemostasis, platelet plug formation, etc. The tremendous growth in the market is expected due to the rising number of surgeries worldwide. Hemophilia or Immune Thrombocytopenia is a disorder where the blood doesn’t clot in a typical way. Hemophilia type A affects 1 in 5,000 male children, and in the United States, The(Hemophilia A) disease affects approximately 400 babies per year. According to the Centers for Disease Control and Prevention (CDC), more than 45% of the population in the United States suffers from at least one chronic condition that requires proper care. Every year, approximately 2 million people die from hemorrhage worldwide, out of which almost 1.5 million deaths are due to physical trauma. In the United States, nearly 60,000 people die from hemorrhaging and blood loss each year. Global Hemostats and Tissue Sealants Market Impact Under COVID-19: The outbreak of the COVID-19 pandemic had a considerable impact on the market during the forecasted period. COVID-19 causes thrombotic complications and bleeding, a significant cause of morbidity in patients affected by the virus. D-dimer elevation during admission was predictive of bleeding, critical illness, thrombosis, and death in patients suffering from COVID-19. Thereby the market for Global Hemostats and Tissue Sealants Market experienced an upswing during and after the post-Covid-19 outbreak. Market Dynamics: - Market Drivers: - The introduction of Fibrin Sealant Products has led to a rising prevalence in adhesion prevention, expanded the areas of applications in drug delivery mechanisms, and is fuelling the overall market growth. As a result, the Fibrin Sealant market is growing steadily at a CAGR of 7.23% and will reach USD 1.39 Billion by 2028. Restraints: - High cost of surgical procedures The higher cost of surgical procedures and the lack of reimbursement for hemostats and sealants products are the significant reasons restricting the overall growth of the market. For the patients who are not covered by health insurance, the cost of brain hemorrhage surgery would pile up to USD 1,50,000 or more. Opportunities: - Increasing prevalence of MIS (Minimally Invasive Surgeries) The preferences for MIS (Minimally Invasive Surgeries) have increased drastically over the past few years. It is because MIS has a lot of advantages like shorter hospital stays, less recovery time, etc., and is likely to dominate the market in the future resulting in the rise of the Global Hemostats and Tissue Sealants Market share. Global Hemostats And Tissue Sealants Market:- Segmentation Analysis: The WorldwideHemostasis and Tissue Sealing Agents Market are broadly segmented based on Product Type, End-User, And Regions. Based on Product Type Topical Hemostat Mechanical Hemostats ORC based Topical Hemostats Collagen-based Topical Hemostats Gelatin based Topical Hemostats Polysaccharide based Topical Hemostats Flowable Hemostats Active Hemostats Adhesive and Tissue Sealing Agents Adhesion Barrier Products Synthetic Tissue Sealant Natural Tissue Sealant Based on End-User Hospitals Ambulatory Surgical Centers Speciality Clinics Based on Regions North America US Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Japan Malaysia Singapore South Korea Thailand Indonesia Philippines Australia Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Report Attribute Details Forecast Period 2020 - 2028 Market size value in 2020 USD 6.35 billion Revenue forecast in 2028 USD 11.27 billion Growth rate CAGR of approximately 8.93% Base year for estimation 2020 Historical data 2015 – 2019 Unit USD Billion, CAGR (2020 - 2028) Segmentation By Product Type, By Application, By End Users, By Region By Product Type Topical Hemostat (Mechanical Hemostats (ORC based Topical Hemostats, Collagen-based, Gelatin based)), (Polysaccharide based Topical Hemostats (Flowable Hemostats, Active Hemostats)), Adhesive and Tissue Sealing Agents (Adhesion Barrier Products, Synthetic Tissue Sealant, Natural Tissue Sealant) By End-User Hospitals, Ambulatory Surgical CentersSpeciality Clinics By Region North America, Europe, Asia-Pacific, LAMEA. Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Advanced Medical Solutions Group plc, Baxter, Cohera MedicalInc, CryoLife Inc, C.R. BardInc, Integra Life Sciences Corporation, Johnson & Johnson ServicesInc, Pfizer Inc, B Braun Medical Inc, Cohesion Technologies Inc Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Based on Product Type, the ‘Topical Hemostat’ segment dominated the market with a CAGR of 7.13% with a revenue of USD 3.42 billion in 2020and is projected to propel rapidly over the forecasted period. Topical hemostats play a crucial role in restricting the bleeding in surgical procedures when conventional procedures become ineffective or impractical. Based on End-User, the ‘Hospitals’ segment dominated the market significantly over the forecasted period due to a higher patient preference for hospitals over other healthcare facilities for hemorrhage treatments. Based on Regions, ‘North America’ dominated the market with a steady CAGR of 8.23% due to the rise in in-patient and outpatient surgical procedures and the continuous increase in demand for hemostat products. Moreover, the Asia Pacific region has the fastest growth with a robust CAGR over the forecasted period due to the steep increase in surgical processes. Global HemostatsAnd Tissue Sealants Market: Competitive Landscape Competitive landscape analysis is the most crucial factor for figuring out the notable competitors in the market environment worldwide. Therefore, the comparison is solely performed based on the expenditure in the field of R&D, market capability, global presence, market initiatives, company overview and financials, overall revenue generated, production capacity, production facilities and sites, organization flaws and strengths, etc. The major players that are mapped and triangulated in the Global Hemostasis and Tissue Sealing Agents Market report are: Advanced Medical Solutions Group plc Baxter Cohera MedicalInc CryoLife Inc C.R. BardInc Integra Life Sciences Corporation Johnson & Johnson ServicesInc Pfizer Inc B Braun Medical Inc Cohesion Technologies Inc Global Hemostats and Tissue Sealants Market: Recent Development: - On July 2021, Baxter supported the analytical demonstration of Clinical& Economic Benefits of Effective Intraoperative Blood Management for Surgical Patients. It demonstrated that the implementation of active hemostatic products would result in lower rates of bleeding-related complications, shorter duration of hospital stays, and decreased hospital expenditures compared to the combined usage of active and passive hemostats. On July 2019, Sangamo and Pizer announce their study result for sb-525 investigational hemophilia a gene therapy showing a sustained increase in factor viii levels Frequently Asked Question About This Report Which geographical region is leading in the global market? North america dominates in the global market with an overall CAGR of 8.23% and will continue to do so over the forecasted period. Which is the leading and dominant end user segment in the global market? ‘Hospitals’ segment is the leading and dominant end user segment in the global market. How big is the hemostats and tissue sealants market? The global hemostats and tissue sealants market size was $6.35 billion in 2020 and is predicted to reach $11.27 billion by 2028, with a CAGR of 8.93%. What is the hemostats and tissue sealants market growth? The global hemostats and tissue sealants market is expected to grow at a compound annual growth rate (CAGR) of 8.93% from 2020 to 2028 to reach USD 11.27 billion by 2028. Which is the leading product segment in the global market? ‘Topical Hemostat’ is the leading product segment in the global market. . Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Topical Hemostat to Witness Highest CAGR in Market, By Product Type, During Forecast Period Figure 11: Hospitals Higher CAGR in Market for End-User Segment during Forecast Period Figure 12: North America to Account for Largest Share of Global Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 13: Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Hemostats and Tissue Sealants Market 5.2.1 Global market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Market, by region, 2020 - 2028 (USD Million) 5.4 Product Type Segment Analysis 5.4.1 Market, by Product Type, 2020 - 2028 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Market, By End-User, 2020 - 2028 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 Market PEST analysis 5.8.2 Market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 14 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 15 Market Drivers and Their Impact 6.2.2 Restraints Figure 16 Market Restraints and Their Impact 6.2.3 Opportunities Figure 17 Market Opportunities and Their Impact 6.2.4 Challenges Figure 18 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 19 Value Chain Analysis: Market 6.5 Ecosystem Figure 20 Market: Ecosystem Table 3 Market: Ecosystem Figure 21 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 22 Top 10 Companies with Highest No. of Patents in Last 9 Years Figure 23 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Market 6.7 Trade Analysis 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 6: Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 7 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Country) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 8: Key Player's market share Figure 24: Key player's market share of companies 7.2 Manufacturers Manufacturing Sites, Area Served, Product Type 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Product Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 9 Market, By Product Type, 2021–2028 (USD Million) Figure 25 Market, By Product Type Figure 26 Topical Hemostat Segment to Register Highest CAGR in Market During Forecast Period 8.3 Topical Hemostat 8.3.1 Topical Hemostat market, 2020 - 2028 (USD Million) 8.3.1.1 Mechanical Hemostats market, 2020 - 2028 (USD Million) 8.3.2 ORC based Topical Hemostats market, 2020 - 2028 (USD Million) 8.3.3 Collagen-based Topical Hemostats market, 2020 - 2028 (USD Million) 8.3.4 Gelatin based Topical Hemostats market, 2020 - 2028 (USD Million) 8.3.4.1 Polysaccharide based Topical Hemostats market, 2020 - 2028 (USD Million) 8.3.5 Flowable Hemostats market, 2020 - 2028 (USD Million) 8.3.6 Active Hemostats market, 2020 - 2028 (USD Million) Figure 27: Topical Hemostat market, 2020 - 2028 (USD Million) 8.4 Adhesive and Tissue Sealing Agents 8.4.1 Adhesive and Tissue Sealing Agents market, 2020 - 2028 (USD Million) 8.4.1.1 Adhesion Barrier Products market, 2020 - 2028 (USD Million) 8.4.1.2 Synthetic Tissue Sealant market, 2020 - 2028 (USD Million) 8.4.1.3 Natural Tissue Sealant market, 2020 - 2028 (USD Million) Figure 28: Adhesive and Tissue Sealing Agents market, 2020 - 2028 (USD Million) Chapter 9. Global Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 10: Market, By End-User, 2021–2028 (USD Million) Figure 29: Market, By End-User, 2021–2028 (USD Million) Figure 30: Hospitals Segment to Register Highest CAGR in Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2020 - 2028 (USD Million) Figure 31: Hospitals market, 2020 - 2028 (USD Million) 9.4 Ambulatory Surgical Centers 9.4.1 Ambulatory Surgical Centers Market, 2020 - 2028 (USD Million) Figure 32: Ambulatory Surgical Centers Market, 2020 - 2028 (USD Million) 9.5 Specialty Clinics 9.5.1 Specialty Clinics market, 2020 - 2028 (USD Million) Figure 33: Specialty Clinics market, 2020 - 2028 (USD Million) Chapter 10. Global Market: Regional Outlook 10.1 North America Figure 34: North America Market, By Revenue Forecast (2020-2028) 10.1.1 North America market, by country, 2020 - 2028 (USD Million) Table 11: North America Market, by Country, 2020-2028 Figure 35: North America Market 10.1.2 North America Market, by Product Type, 2020 - 2028 (USD Million) Table12: North America Market, by Product Type, 2020 - 2028 (USD Million) Figure 36: North America Market, by Product Type, 2020 - 2028 (USD Million) 10.1.3 North America Market, by End-User, 2020 - 2028 (USD Million) Table 13: North America Market, by End-User, 2020 - 2028 (USD Million) Figure 37: North America Market, by End-User, 2020 - 2028 (USD Million) 10.1.4 U.S. 10.1.4.1 U.S. market, by Product Type, 2020 - 2028 (USD Million) Figure 38: U.S. Market, by Product Type, 2020 - 2028 (USD Million) 10.1.4.2 U.S. Market, by End-User, 2020 - 2028 (USD Million) Figure 39: U.S. Market, by End-User, 2020 - 2028 (USD Million) 10.1.5 Canada 10.1.5.1 Canada Market, by Product Type, 2020 - 2028 (USD Million) Figure 40: Canada Market, by Product Type, 2020 - 2028 (USD Million) 10.1.5.2 Canada Market, by End-User, 2020 - 2028 (USD Million) Figure 41: Canada Market, by End-User, 2020 - 2028 (USD Million) Figure 42: Canada Market, by End-User, 2020 - 2028 (USD Million) Figure 43: Canada Market, by End-User, 2020 - 2028 (USD Million) 10.2 Europe Figure 44: Europe Market, By Revenue Forecast (2020-2028) 10.2.1 Europe market, by country, 2020 - 2028 (USD Million) Table 14: Europe market, by country, 2020 - 2028 (USD Million) Figure 45: Europe market, by country, 2020 - 2028 (USD Million) 10.2.2 Europe Market, by Product Type, 2020 - 2028 (USD Million) Table 15: Europe Market, by Product Type, 2020 - 2028 (USD Million) Figure 46: Europe Market, by Product Type, 2020 - 2028 (USD Million) 10.2.3 Europe market, by End-User, 2020 - 2028 (USD Million) Table 16: Europe Market, by End-User, 2020 - 2028 (USD Million) Figure 47: Europe Market, by End-User, 2020 - 2028 (USD Million) 10.2.4 U.K. 10.2.4.1 U.K. Market, by Product Type, 2020 - 2028 (USD Million) Figure 48: U.K. Market, by Product Type, 2020 - 2028 (USD Million) 10.2.4.2 U.K. Market, by End-User, 2020 - 2028 (USD Million) Figure 49: U.K. Market, by End-User, 2020 - 2028 (USD Million) 10.2.5 Germany 10.2.5.1 Germany Market, by Product Type, 2020 - 2028 (USD Million) Figure 50: Germany Market, by Product Type, 2020 - 2028 (USD Million) 10.2.5.2 Germany Market, by End-User, 2020 - 2028 (USD Million) Figure 51: Germany Market, by End-User, 2020 - 2028 (USD Million) 10.2.6 France 10.2.6.1 France Market, by Product Type, 2020 - 2028 (USD Million) Figure 52: France Market, by Product Type, 2020 - 2028 (USD Million) 10.2.6.2 France Market, by End-User, 2020 - 2028 (USD Million) Figure 53: France Market, by End-User, 2020 - 2028 (USD Million) 10.2.7 Rest of Europe 10.2.7.1 Rest of Europe Market, by Product Type, 2020 - 2028 (USD Million) Figure 54: Rest of Europe Market, by Product Type, 2020 - 2028 (USD Million) 10.2.7.2 Rest of Europe Market, by End-User, 2020 - 2028 (USD Million) Figure 55: Rest of Europe Market, by End-User, 2020 - 2028 (USD Million) 10.3 Asia Pacific Figure 56: Asia Pacific Market, By Revenue Forecast (2020-2028) 10.3.1 Asia Pacific market, by country, 2020 - 2028 (USD Million) Table 17: Asia Pacific market, by country, 2020 - 2028 (USD Million) Figure 57: Asia Pacific market, by country, 2020 - 2028 (USD Million) 10.3.2 Asia Pacific Market, by Product Type, 2020 - 2028 (USD Million) Table 18: Asia Pacific Market, by Product Type, 2020 - 2028 (USD Million) Figure 58: Asia Pacific Market, by Product Type, 2020 - 2028 (USD Million) 10.3.3 Asia Pacific Market, by End-User, 2020 - 2028 (USD Million) Table 19: Asia Pacific Market, by End-User, 2020 - 2028 (USD Million) Figure 59: Asia Pacific Market, by End-User, 2020 - 2028 (USD Million) 10.3.4 China 10.3.4.1 China market, by Product Type, 2020 - 2028 (USD Million) Figure 60: China Market, by Product Type, 2020 - 2028 (USD Million) 10.3.4.2 China Market, by End-User, 2020 - 2028 (USD Million) Figure 61: China Market, by End-User, 2020 - 2028 (USD Million) 10.3.5 India 10.3.5.1 India Market, by Product Type, 2020 - 2028 (USD Million) Figure 62: India Market, by Product Type, 2020 - 2028 (USD Million) 10.3.5.2 India Market, by End-User, 2020 - 2028 (USD Million) Figure 63: India Market, by End-User, 2020 - 2028 (USD Million) 10.3.6 Japan 10.3.6.1 Japan Market, by Product Type, 2020 - 2028 (USD Million) Figure 64: Japan Market, by Product Type, 2020 - 2028 (USD Million) 10.3.6.2 Japan Market, by End-User, 2020 - 2028 (USD Million) Figure 65: Japan Market, by End-User, 2020 - 2028 (USD Million) 10.3.7 South Korea 10.3.7.1 South Korea Market, by Product Type, 2020 - 2028 (USD Million) Figure 66: South Korea Market, by Product Type, 2020 - 2028 (USD Million) 10.3.7.2 South Korea Market, by End-User, 2020 - 2028 (USD Million) Figure 67: South Korea Market, by End-User, 2020 - 2028 (USD Million) 10.3.8 Rest of APAC 10.3.8.1 Rest of APAC Market, by Product Type, 2020 - 2028 (USD Million) Figure 68: Rest of APAC Market, by Product Type, 2020 - 2028 (USD Million) 10.3.8.2 Rest of APAC Market, by End-User, 2020 - 2028 (USD Million) Figure 69: Rest of APAC Market, by End-User, 2020 - 2028 (USD Million) 10.4 Latin America Figure 70: Latin America Market, By Revenue Forecast (2020-2028) 10.4.1 Latin America market, by country, 2020 - 2028 (USD Million) Table 20: Latin America market, by country, 2020 - 2028 (USD Million) Figure 71: Latin America market, by country, 2020 - 2028 (USD Million) 10.4.2 Latin America Market, by Product Type, 2020 - 2028 (USD Million) Table 21: Latin America Market, by Product Type, 2020 - 2028 (USD Million) Figure 72: Latin America Market, by Product Type, 2020 - 2028 (USD Million) 10.4.3 Latin America Market, by End-User, 2020 - 2028 (USD Million) Table 22: Latin America Market, by End-User, 2020 - 2028 (USD Million) Figure 73: Latin America Market, by End-User, 2020 - 2028 (USD Million) 10.4.4 Brazil 10.4.4.1 Brazil Market, by Product Type, 2020 - 2028 (USD Million) Figure 74: Brazil market, by Product Type, 2020 - 2028 (USD Million) 10.4.4.2 Brazil Market, by End-User, 2020 - 2028 (USD Million) Figure 75: Brazil Market, by End-User, 2020 - 2028 (USD Million) 10.4.5 Mexico 10.4.5.1 Mexico Market, by Product Type, 2020 - 2028 (USD Million) Figure 76: Mexico Market, by Product Type, 2020 - 2028 (USD Million) 10.4.5 2 Mexico Market, by End-User, 2020 - 2028 (USD Million) Figure 77: Mexico Market, by End-User, 2020 - 2028 (USD Million) 10.4.6 Rest of Latin America 10.4.6.1 Rest of the Latin America Market, by Product Type, 2020 - 2028 (USD Million) Figure 78: Rest of the Latin America Market, by Product Type, 2020 - 2028 (USD Million) 10.4.6.2 Rest of the Latin America Market, by End-User, 2020 - 2028 (USD Million) Figure 79: Rest of the Latin America Market, by End-User, 2020 - 2028 (USD Million) 10.5 MEA Figure 80: MEA Market, By Revenue Forecast (2020-2028) 10.5.1 MEA Market, by Product Type, 2020 - 2028 (USD Million) Figure 81: MEA Market, by Product Type, 2020 - 2028 (USD Million) 10.5.2 MEA Market, by End-User, 2020 - 2028 (USD Million) Figure 82: MEA Market, by End-User, 2020 - 2028 (USD Million) Chapter 11. Competitive Landscape 11.1 Advanced Medical Solutions Group plc. 11.1.1 Company overview 11.1.2 Financial performance 11.1.3 Product Portfolio Analysis 11.1.4 Business Strategy & Recent Development 11.2 Baxter. 11.2 .1 Company overview 11.2. 2 Financial performance 11.2 .3 Product Portfolio Analysis 11.2 .4 Business Strategy & Recent Development 11.3 Cohera MedicalInc. 11.3.1 Company overview 11.3.2 Financial performance 11.3.3 Product Portfolio Analysis 11.3.4 Business Strategy & Recent Development 11.4 CryoLife Inc. 11.4.1 Company overview 11.4.2 Financial performance 11.4.3 Product Portfolio Analysis 11.4.4 Business Strategy & Recent Development 11.5 C.R. BardInc. 11.5.1 Company overview 11.5.2 Financial performance 11.5.3 Product Portfolio Analysis 11.5.4 Business Strategy & Recent Development 11.6 Integra Life Sciences Corporation. 11.6.1 Company overview 11.6.2 Financial performance 11.6.3 Product Portfolio Analysis 11.6.4 Business Strategy & Recent Development 11.7 Johnson & Johnson ServicesInc. 11.7.1 Company overview 11.7.2 Financial performance 11.7.3 Product Portfolio Analysis 11.7.4 Business Strategy & Recent Development 11.8 Pfizer Inc. 11.8.1 Company overview 11.8.2 Financial performance 11.8.3 Product Portfolio Analysis 11.8.4 Business Strategy & Recent Development 11.9 B Braun Medical Inc. 11.9.1 Company overview 11.9.2 Financial performance 11.9.3 Product Portfolio Analysis 11.9.4 Business Strategy & Recent Development 11.10 Cohesion Technologies Inc. 11.10.1 Company overview 11.10.2 Financial performance 11.10.3 Product Portfolio Analysis 11.10.4 Business Strategy & Recent Development